thiazoles has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brosnan, CF; Dumitrescu-Ozimek, L; Feinstein, DL; Galea, E; Gavrilyuk, V; Heneka, MT; Landreth, GE; Pershadsingh, HA; Weinberg, G; Whitacre, CC | 1 |
| Assaf, B; Camelo, S; Dangond, F; De Girolami, U; Due, B; Duran, G; Ferrante, RJ; Gray, SG; Hwang, D; Iglesias, AH; Imitola, J; Khoury, SJ; Langley, B; Ratan, RR; Ryu, H; Smith, K; Stephanopoulos, G | 1 |
| Dello Russo, C; Feinstein, DL; Gavrilyuk, V; Kalinin, S; Peters, JM; Polak, PE; Richardson, J; Sharp, A; Weinberg, G; Willson, TM | 1 |
| Axtell, R; Bhat, R; Chawla, A; Dugas, JC; Dunn, SE; Johnson, A; Moshkova, M; Mukundan, L; Nguyen, K; Sobel, RA; Steinman, L; Straus, DS | 1 |
| Jhaveri, A; Kenison, JE; Khadse, N; Li, Z; Nowakowska, D; Plasencia, A; Quintana, FJ; Sherr, DH; Stanton, VP; Tezza, S; Tjon, E | 1 |
5 other study(ies) available for thiazoles and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Topics: Animals; Cerebellum; Cerebral Cortex; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Humans; Hypoglycemic Agents; I-kappa B Proteins; Ligands; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxazoles; Peptide Fragments; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Remission Induction; Spinal Cord; T-Lymphocytes; Thiazoles; Thiazolidinediones; Transcription Factors; Tyrosine | 2002 |
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Profiling; Gene Expression Regulation; Glycoproteins; Hydroxamic Acids; Immunohistochemistry; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neurons; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Spleen; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
Topics: Animals; Brain; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Glycoproteins; Immunohistochemistry; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Peptide Fragments; PPAR delta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Thiazoles; Time Factors | 2005 |
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
Topics: Animals; Brain; CD4-Positive T-Lymphocytes; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Glycoproteins; Homeodomain Proteins; Humans; Interferon-gamma; Interleukin-12; Interleukin-17; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Myeloid Cells; Nuclear Receptor Subfamily 1, Group F, Member 3; Peptide Fragments; PPAR delta; Spinal Cord; T-Box Domain Proteins; T-Lymphocytes, Helper-Inducer; Th1 Cells; Thiazoles; Tumor Necrosis Factor-alpha | 2010 |
Tolerogenic nanoparticles suppress central nervous system inflammation.
Topics: Animals; Bystander Effect; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Humans; Immune Tolerance; Immunosuppressive Agents; Indoles; Liposomes; Mice; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nanoparticles; Peptide Fragments; Receptors, Aryl Hydrocarbon; Signal Transduction; T-Lymphocytes, Regulatory; Thiazoles | 2020 |